California Public Employees Retirement System’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-67,400
Closed -$1.75M 2595
2021
Q1
$1.75M Sell
67,400
-7,973
-11% -$202K ﹤0.01% 2104
2020
Q4
$1.52M Buy
75,373
+380
+0.5% +$8.18K ﹤0.01% 2186
2020
Q3
$1.47M Buy
74,993
+24,993
+50% +$469K ﹤0.01% 2010
2020
Q2
$883K Buy
+50,000
New +$627K ﹤0.01% 2320

Other funds holding PTGX

California Public Employees Retirement System's PTGX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Protagonist Therapeutics (PTGX) in Q2 2021, closing a stake of 67,400 shares — an estimated $1.75M sold.

California Public Employees Retirement System first reported a position in PTGX in Q2 2020 and held it in 4 quarters. The position peaked at $1.75M in Q1 2021. 138 funds tracked by Wall St. Rank hold PTGX as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Protagonist Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 67,400 Protagonist Therapeutics shares in Q2 2021, an estimated $1.75M.
  • California Public Employees Retirement System first reported a position in Protagonist Therapeutics in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Protagonist Therapeutics position peaked at $1.75M in Q1 2021.
  • 138 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.